RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 103 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $2,972,000 | +67.2% | 331,351 | +0.1% | 0.00% | +100.0% |
Q2 2016 | $1,777,000 | +33.8% | 330,867 | +14.6% | 0.00% | 0.0% |
Q1 2016 | $1,328,000 | -10.5% | 288,637 | +1.2% | 0.00% | 0.0% |
Q4 2015 | $1,483,000 | -14.1% | 285,237 | -0.1% | 0.00% | 0.0% |
Q3 2015 | $1,727,000 | -61.8% | 285,467 | -0.2% | 0.00% | -66.7% |
Q2 2015 | $4,516,000 | +105.8% | 285,995 | +41.7% | 0.01% | +100.0% |
Q1 2015 | $2,194,000 | +14.8% | 201,819 | +11.1% | 0.00% | 0.0% |
Q4 2014 | $1,911,000 | +9.3% | 181,680 | -0.3% | 0.00% | +50.0% |
Q3 2014 | $1,748,000 | -16.2% | 182,289 | +0.9% | 0.00% | -33.3% |
Q2 2014 | $2,087,000 | +26.3% | 180,730 | +9.4% | 0.00% | +50.0% |
Q1 2014 | $1,653,000 | -22.3% | 165,265 | +1.1% | 0.00% | -33.3% |
Q4 2013 | $2,128,000 | -14.5% | 163,459 | -2.1% | 0.00% | -25.0% |
Q3 2013 | $2,490,000 | +81.0% | 166,909 | +13.4% | 0.00% | +100.0% |
Q2 2013 | $1,376,000 | – | 147,125 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 16,355 | $244,000 | 3.04% |
EAM Investors, LLC | 175,761 | $2,626,000 | 0.52% |
Tekla Capital Management LLC | 110,000 | $1,643,000 | 0.18% |
Jane Street Holding, LLC | 447,456 | $6,676,000 | 0.08% |
A.R.T. Advisors, LLC | 95,164 | $1,419,000 | 0.08% |
CREDIT SUISSE AG/ | 5,079,886 | $75,792,000 | 0.08% |
NOMURA HOLDINGS INC | 736,362 | $10,936,000 | 0.07% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $14,920,000 | 0.04% |
ROYAL BANK OF CANADA | 2,971,616 | $44,337,000 | 0.03% |
LORD, ABBETT & CO. LLC | 721,849 | $10,784,000 | 0.02% |